Amazon Eyes Pharmacies

 | Nov 18, 2020 07:22AM ET

The previous week has been good for shareholders of pharmacies such as CVS and Walgreens following vaccine data from Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA). The two stand to benefit if and when a vaccine comes to market and have already struck a deal with the U.S. Centers for Disease Control to administer the vaccine at long-term care facilities.

With shares of CVS (NYSE:CVS) and Walgreens (NASDAQ:WBA) each having gained about 30% so far for the month through Monday, Amazon (NASDAQ:AMZN) sent them crashing down yesterday with one press release.

Amazon announced two new pharmacy offerings as it eyes pharmacies as the next sector to go after. Amazon has been eyeing the space for a few years following its nearly $1 billion acquisition of PillPack in 2018.

Amazon Pharmacy will let customers order their prescription medicines from Amazon and have them delivered to their homes, with Prime Members getting free two-day delivery. Users can create a secure pharmacy profile that stores insurance and prescription information. Amazon Pharmacy will be available in every state except for Hawaii, Illinois, Kentucky, Louisiana and Minnesota.